BNP Paribas Financial Markets trimmed its position in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 32.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,218 shares of the semiconductor company's stock after selling 11,488 shares during the quarter. BNP Paribas Financial Markets owned 0.07% of Silicon Laboratories worth $2,799,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cullen Frost Bankers Inc. bought a new stake in shares of Silicon Laboratories in the 2nd quarter worth approximately $28,000. Advisors Asset Management Inc. boosted its stake in shares of Silicon Laboratories by 159.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company's stock valued at $32,000 after purchasing an additional 169 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Silicon Laboratories by 84.1% during the third quarter. GAMMA Investing LLC now owns 497 shares of the semiconductor company's stock valued at $57,000 after buying an additional 227 shares during the period. Daiwa Securities Group Inc. bought a new position in Silicon Laboratories in the second quarter worth about $60,000. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new stake in Silicon Laboratories in the second quarter worth about $82,000.
Wall Street Analysts Forecast Growth
SLAB has been the topic of a number of research analyst reports. Stifel Nicolaus reduced their target price on Silicon Laboratories from $160.00 to $135.00 and set a "buy" rating on the stock in a report on Tuesday, November 5th. Morgan Stanley reduced their price target on Silicon Laboratories from $123.00 to $97.00 and set an "equal weight" rating on the stock in a research note on Tuesday, November 5th. JPMorgan Chase & Co. lowered their price objective on Silicon Laboratories from $150.00 to $135.00 and set an "overweight" rating for the company in a research report on Tuesday, November 5th. Barclays decreased their price target on shares of Silicon Laboratories from $120.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, November 5th. Finally, KeyCorp dropped their price objective on shares of Silicon Laboratories from $150.00 to $115.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat, Silicon Laboratories has an average rating of "Hold" and a consensus target price of $121.50.
Get Our Latest Research Report on SLAB
Silicon Laboratories Stock Up 6.0 %
Shares of NASDAQ SLAB traded up $6.64 during midday trading on Friday, hitting $116.41. The stock had a trading volume of 245,336 shares, compared to its average volume of 298,268. The business's 50 day moving average is $110.76 and its 200-day moving average is $113.09. Silicon Laboratories Inc. has a 52 week low of $94.00 and a 52 week high of $154.91. The company has a market cap of $3.78 billion, a P/E ratio of -15.59 and a beta of 1.21.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.07. The business had revenue of $166.00 million for the quarter, compared to analysts' expectations of $165.50 million. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. The firm's quarterly revenue was down 18.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.48 EPS. As a group, analysts expect that Silicon Laboratories Inc. will post -3.56 EPS for the current fiscal year.
About Silicon Laboratories
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.